Decision making as a predictor of first ecstasy use: a prospective study

Psychopharmacology (Berl). 2009 Apr;203(3):519-27. doi: 10.1007/s00213-008-1398-y. Epub 2008 Nov 20.

Abstract

Rationale: Ecstasy (+/-3,4-methylenedioxymethamphetamine) is a widely used recreational drug that may damage the serotonin system and may entail neuropsychological dysfunctions. Few studies investigated predictors for ecstasy use. Self-reported impulsivity does not predict the initiation of ecstasy use; the question is if neuropsychological indicators of impulsivity can predict first ecstasy use.

Objective: This study tested the hypothesis that a neuropsychological indicator of impulsivity predicts initiation of ecstasy use.

Materials and methods: Decision-making strategy and decision-making reaction times were examined with the Iowa Gambling Task in 149 ecstasy-naive subjects. The performance of 59 subjects who initiated ecstasy use during a mean follow-up period of 18 months (range, 11-26) was compared with the performance of 90 subjects that remained ecstasy-naive.

Results: Significant differences in decision-making strategy between female future ecstasy users and female persistent ecstasy-naive subjects were found. In addition, the gap between decision-making reaction time after advantageous choices and reaction time after disadvantageous choices was smaller in future ecstasy users than in persistent ecstasy-naives.

Conclusion: Decision-making strategy on a gambling task was predictive for future use of ecstasy in female subjects. Differences in decision-making time between future ecstasy users and persistent ecstasy-naives may point to lower punishment sensitivity or higher impulsivity in future ecstasy users. Because differences were small, the clinical relevance is questionable.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Amphetamine-Related Disorders / psychology*
  • Decision Making*
  • Female
  • Forecasting
  • Gambling / psychology
  • Humans
  • Male
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Neuropsychological Tests
  • Prospective Studies
  • Time Factors
  • Young Adult

Substances

  • N-Methyl-3,4-methylenedioxyamphetamine